BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38325596)

  • 21. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
    Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM
    Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models of multiple endocrine neoplasia.
    Wiedemann T; Pellegata NS
    Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polyadenomatoses: type 2 multiple endocrine neoplasms].
    Conte-Devolx B; Niccoli-Sire P;
    Presse Med; 2002 Aug; 31(26):1224-30. PubMed ID: 12212516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple endocrine neoplasia syndromes. Type 2].
    Juodele L; Juozaityte E; Zindzius A; Pundzius J
    Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasms.
    Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):149-63. PubMed ID: 18328987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple endocrine neoplasia type 2.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and signaling effects of RET D631Y variant multiple endocrine neoplasia type 2 (MEN2).
    Lee JY; Kim SY; Jo KH; Mo EY; Kim ES; Kim HS; Han JH; Moon SD
    Korean J Intern Med; 2022 Mar; 37(2):398-410. PubMed ID: 34905813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
    Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
    Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid tumors associated with multiple endocrine neoplasias.
    Almeida MQ; Stratakis CA
    Cancer Genet Cytogenet; 2010 Nov; 203(1):30-6. PubMed ID: 20951316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia syndromes associated with mutation of p27.
    Lee M; Pellegata NS
    J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
    Chevalier B; Coppin L; Romanet P; Cuny T; Maiza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
    J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38288531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multiple endocrine neoplasia type 2].
    Niccoli-Sire P; Conte-Devolx B
    Ann Endocrinol (Paris); 2007 Oct; 68(5):317-24. PubMed ID: 17626779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
    Raue F; Frank-Raue K
    Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
    Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
    Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.